366 related articles for article (PubMed ID: 21930108)
1. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Rosen JE; Chan L; Shieh DB; Gu FX
Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
4. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
[TBL] [Abstract][Full Text] [Related]
5. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
[TBL] [Abstract][Full Text] [Related]
7. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
9. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
11. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
12. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
Lam T; Pouliot P; Avti PK; Lesage F; Kakkar AK
Adv Colloid Interface Sci; 2013 Nov; 199-200():95-113. PubMed ID: 23891347
[TBL] [Abstract][Full Text] [Related]
14. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy.
Lin MM; Kim HH; Kim H; Dobson J; Kim DK
Nanomedicine (Lond); 2010 Jan; 5(1):109-33. PubMed ID: 20025469
[TBL] [Abstract][Full Text] [Related]
15. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
[TBL] [Abstract][Full Text] [Related]
16. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.
Yu MK; Jeong YY; Park J; Park S; Kim JW; Min JJ; Kim K; Jon S
Angew Chem Int Ed Engl; 2008; 47(29):5362-5. PubMed ID: 18551493
[No Abstract] [Full Text] [Related]
17. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
Hu F; Jia Q; Li Y; Gao M
Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
19. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci.
Subbiahdoss G; Sharifi S; Grijpma DW; Laurent S; van der Mei HC; Mahmoudi M; Busscher HJ
Acta Biomater; 2012 Jul; 8(6):2047-55. PubMed ID: 22406508
[TBL] [Abstract][Full Text] [Related]
20. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides.
Kumar A; Sahoo B; Montpetit A; Behera S; Lockey RF; Mohapatra SS
Nanomedicine; 2007 Jun; 3(2):132-7. PubMed ID: 17572355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
